Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound

Por Baazaoui, Narjes, Iqbal, Khalid
Publicado no Alzheimers Res Ther (2017)

A Novel Therapeutic Approach to Treat Alzheimer’s Disease by Neurotrophic Support During the Period of Synaptic Compensation

Por Baazaoui, Narjes, Iqbal, Khalid
Publicado no J Alzheimers Dis (2018)

Glutamine synthetase in muscle and kidney

Por Iqbal, Khalid, Ottaway, J. H.
Publicado em 1970

Tau Pathology Generated by Overexpression of Tau

Por Grundke-Iqbal, Inge, Iqbal, Khalid
Publicado em 1999

Alzheimer Disease, a Multifactorial Disorder Seeking Multi-therapies

Por Iqbal, Khalid, Grundke-Iqbal, Inge
Publicado em 2010

Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer’s disease

Por Kazim, Syed Faraz, Iqbal, Khalid
Publicado no Mol Neurodegener (2016)

Up-Regulation of Inhibitors of Protein Phosphatase-2A in Alzheimer’s Disease

Por Tanimukai, Hitoshi, Grundke-Iqbal, Inge, Iqbal, Khalid
Publicado em 2005

O-GlcNAc cycling modulates neurodegeneration

Por Gong, Cheng-Xin, Liu, Fei, Iqbal, Khalid
Publicado em 2012

The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives

Por Wanka, Lukas, Iqbal, Khalid, Schreiner, Peter R.
Publicado em 2013

Hyperphosphorylation-Induced Tau Oligomers

Por Iqbal, Khalid, Gong, Cheng-Xin, Liu, Fei
Publicado em 2013

Alzheimer Disease Therapeutics: Focus on the Disease and Not Just Plaques and Tangles

Por Iqbal, Khalid, Liu, Fei, Gong, Cheng-Xin
Publicado em 2014

Dynamic Regulation of Expression and Phosphorylation of Tau by Fibroblast Growth Factor-2 In Neural Progenitor Cells from Adult Rat Hippocampus

Por Tatebayashi, Yoshitaka, Iqbal, Khalid, Grundke-Iqbal, Inge
Publicado no J Neurosci (1999)

Efficacy of probiotic in perennial allergic rhinitis under five year children: A randomized controlled trial

Por Ahmed, Mubashir, Billoo, Abdul Gaffar, Iqbal, Khalid
Publicado no Pak J Med Sci (2019)

Stratification of Patients is the Way to Go to Develop Neuroprotective/Disease-Modifying Drugs for Alzheimer's Disease

Por Iqbal, Khalid, Chohan, M. Omar, Grundke-Iqbal, Inge
Publicado em 2008

Mycoplasmotic Giant Cell Epitheliomatous Inverted Papillary Carcinoma of the Aural Canal

Por Naim, Mohammed, John, Vanesa T., Kumar, Amit, Iqbal, Khalid
Publicado em 2010

Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration

Por Wang, Jian-Zhi, Grundke-Iqbal, Inge, Iqbal, Khalid
Publicado em 2007

Regulation of Phosphorylation of Tau by Cyclin-dependent Kinase 5 and Glycogen Synthase Kinase-3 at Substrate Level

Por Sengupta, Amitabha, Novak, Michal, Grundke-Iqbal, Inge, Iqbal, Khalid
Publicado em 2006

I PP2A 1 Affects Tau Phosphorylation via Association with the Catalytic Subunit of Protein Phosphatase 2A

Por Chen, She, Li, Bin, Grundke-Iqbal, Inge, Iqbal, Khalid
Publicado em 2008

Cytosolic Abnormally Hyperphosphorylated Tau But Not Paired Helical Filaments Sequester Normal MAPs and Inhibit Microtubule Assembly

Por Iqbal, Khalid, Alonso, Alejandra del C., Grundke-Iqbal, Inge
Publicado em 2008

Shifting balance from neurodegeneration to regeneration of the brain: a novel therapeutic approach to Alzheimer's disease and related neurodegenerative conditions

Por Iqbal, Khalid, Kazim, Syed Faraz, Bolognin, Silvia, Blanchard, Julie
Publicado em 2014